… ]) on coronavirus disease 2019 (COVID-19) outcomes in younger vaccinated adults are
unclear. The objective of this study was to assess if NMV/r use in vaccinated adults aged ≤50 …

… SARS-CoV-2-positive non-hospitalized adults. We conducted a … -CoV-2-positive patients
treated in a COVID-19 virtual outpatient … of COVID-19 illness in non-hospitalized adults differ …

… symptoms experienced by nonhospitalized COVID-19 … To improve COVID-19 disease
recognition, which can help … , we interviewed hospitalized and nonhospitalized COVID-19 patients …

… , nonhospitalized adults at high risk for progression to severe coronavirus disease 2019 (Covid-…
Covid-19–related hospitalization or death from any cause through day 28, viral load, and …

… nonhospitalized patients 18 years of age and older who were vaccinated and subsequently
developed COVID-19 … , or molnupiravir for the index case of COVID-19. Patients were further …

… We enrolled nonhospitalized adults who were required to have 4 or fewer days of symptoms
and either PCR-confirmed SARS-CoV-2 infection or compatible symptoms after a high-risk …

… for severe disease in the pediatric population. We report 177 infected children and young
adults, … characteristics between infected hospitalized and nonhospitalized cohorts, as well as …

Background Monoclonal antibody treatment may prevent complications of coronavirus
disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal …

… for post-COVID-19 sequelae 27 . This analysis included both hospitalized and non-hospitalized
patients and two control groups consisting of patients without COVID-19 and those with …

… ) by regulatory agencies for the treatment of COVID-19 in non-hospitalized persons 2,3,4,5 .
… COVID-19 in non-hospitalized adults with risk factors for progression to severe disease who …